Literature DB >> 9243661

Photodynamic therapy for antifibrosis in a rabbit model of filtration surgery.

R A Hill1, D H Crean, D R Doiron, T J McDonald, L H Liaw, F Ghosheh, A Hamilton, M W Berns.   

Abstract

BACKGROUND AND
OBJECTIVE: The purpose of this pilot study was to investigate the use of photodynamic therapy (PDT) using tin ethyl etiopurpurin (SnET2) as an adjunctive antifibrotic therapy for filtering surgery in a rabbit model.
MATERIALS AND METHODS: The pharmacokinetics of SnET2 were established by intravenous (1 mg/kg) and subconjunctival (25, 50, or 75 micrograms) injections and compared with controls. Intravenous and subconjunctival SnET2 injections were given prior to posterior lip sclerectomies followed by postoperative laser irradiation (664 +/- 7 nm; 100 mW/cm2; 30 J/cm2). Antifibrotic efficacy was established by clinical response and histologic examination.
RESULTS: After subconjunctival injections, large areas of avascular conjunctiva were produced and filtering bleb survival was prolonged. No effect was found for intravenously administered photosensitizer followed by light irradiation.
CONCLUSIONS: PDT may be an alternative antifibrotic therapy for filtration surgery that does not use chemotherapeutic agents or ionizing radiation. Multiple parameters (light, drug dose, irradiation area) may be manipulated to improve predictability of the antifibrotic effect.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9243661

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers        ISSN: 1082-3069


  5 in total

1.  Photodynamic therapy for wound-healing modulation in pterygium surgery. A clinical pilot study.

Authors:  Arno Hueber; Salvatore Grisanti; Michael Diestelhorst
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-04-15       Impact factor: 3.117

2.  Cellular photoablation to control postoperative fibrosis in a rabbit model of filtration surgery.

Authors:  S Grisanti; M Diestelhorst; K Heimann; G Krieglstein
Journal:  Br J Ophthalmol       Date:  1999-12       Impact factor: 4.638

3.  Safety and efficacy of photodynamic therapy using BCECF-AM compared to mitomycin C in controlling post-operative fibrosis in a rabbit model of subscleral trabeculectomy.

Authors:  Azza Mohamed Ahmed Said; Rania Gamal Eldin Zaki; Thanaa Helmy Mohamed; Manal Ibraheem Salman
Journal:  Int J Ophthalmol       Date:  2016-03-18       Impact factor: 1.779

4.  Photodynamic modulation of wound healing in glaucoma filtration surgery.

Authors:  J F Jordan; M Diestelhorst; S Grisanti; G K Krieglstein
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

5.  Comparative study between trabeculectomy with photodynamic therapy (BCECF-AM) and trabeculectomy with antimetabolite (MMC) in the treatment of primary open angle glaucoma.

Authors:  Ahmed M Saeed
Journal:  Clin Ophthalmol       Date:  2012-10-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.